• ACIP reform
• ACIP vote
• chronic disease trends in children
• Engerix-B
• hepatitis B vaccine debate
• infant vaccination policy
• maternal hepatitis B screening
• medical ethics in pediatrics
• newborn vaccination controversy
• pediatric clinical trials
• pediatric vaccination guidelines
• perinatal hepatitis B transmission
• pharmaceutical industry influence
• placebo-controlled trial debate
• public health policy analysis
• recombinant vaccines
• Recombivax HB
• regulatory capture allegations
• RFK Jr vaccine policy
• vaccine clinical trial design
• vaccine consent and parental rights
• vaccine efficacy debate
• vaccine ethics
• vaccine injury act
• vaccine mandates debate
• vaccine risk-benefit analysis
• vaccine safety concerns
• vaccine safety science criticism
• vaccine schedule history

The War Against Pharmaceutical Evil: Zeroing In on the Hepatitis B Vaccine

• 

  LN24 / 2 weeks
• 0
• 14 min read

The CDC’s Advisory Committee on Immunization Practices (also called ACIP or ACIP), it voted 8-3 to recommend shared decision-making for the hepatitis B birth dose in infants born to mothers testing negative for the virus. According to their recommendation, if skipped, vaccination would start no earlier than 2 months of age, while high-risk babies still […]